去年上海生物医药产业规模逾9337亿元 “沪牌”创新药国际竞争力不断提升
中新网上海5月21日电 (记者 郑莹莹)2024上海国际生物技术与医药研讨会21日在上海举办。据上海市科学技术委员会主任骆大进在会上介绍，2023年，上海生物医药产业规模逾9337亿元，同比增长4.9%。
近年来，上海生物医药产业发展迅速，其规模和影响力在我国乃至全球范围内不断扩大。骆大进表示，上海作为中国生物医药产业的核心城市，一直致力于推动产业创新发展，提升“沪牌”创新药的国际竞争力。
据悉，上海在生物医药研发创新、成果转化、产业链完善等方面具有显著优势。2023年，上海生物医药产业同比增长4.9%，表明该产业发展势头良好，为我国生物医药产业的发展做出了积极贡献。
此次研讨会旨在加强国际间生物技术与医药领域的交流与合作，推动产业发展。会议期间，国内外专家学者、企业家共聚一堂，分享最新研究成果，探讨行业发展趋势。
参会人士纷纷表示，随着全球生物技术与医药产业的快速发展，各国在该领域的竞争愈发激烈。在此背景下，上海作为我国生物医药产业的重要基地，有望发挥更大作用，为全球生物医药产业发展贡献力量。
据了解，为继续推动生物医药产业的发展，上海市政府将加大对创新药物研发、成果转化、人才培养等方面的支持力度，加快构建完善的产业链体系，助力“沪牌”创新药走向国际市场，提升我国在全球生物医药产业的竞争力。
展望未来，随着政策扶持和市场需求的双重驱动，上海生物医药产业将继续保持快速发展态势，助力我国在全球生物医药领域的地位不断提升。
英语如下：
### News Title: Shanghai Biomedical Industry Reaches 933.7 Billion Yuan, “Shanghai Brand” Innovative Drugs Enhance Competitiveness
### Keywords: Biomedical industry, Shanghai Brand innovation, industry growth
### News Content: Last year, the scale of Shanghai’s biomedical industry exceeded 933.7 billion yuan, with the international competitiveness of “Shanghai Brand” innovative drugs continuously improving.
**China News Service, Shanghai, May 21st (Reporter Zheng Yiding)** – The 2024 Shanghai International Biotechnology and Pharmaceutical Seminar was held on May 21st in Shanghai. According to Luo Daqing, the Director of the Shanghai Science and Technology Committee, in 2023, the scale of Shanghai’s biomedical industry exceeded 933.7 billion yuan, with a year-on-year growth rate of 4.9%.
In recent years, the biomedical industry in Shanghai has developed rapidly, with its scale and influence continuously expanding within China and globally. Luo Daqing stated that as a core city of China’s biomedical industry, Shanghai has always been committed to promoting innovative development of the industry and enhancing the international competitiveness of “Shanghai Brand” innovative drugs.
It is understood that Shanghai has significant advantages in biomedical research and innovation, result transformation, and the improvement of industrial chains. The 4.9% year-on-year growth rate of Shanghai’s biomedical industry in 2023 indicates a good development momentum and positive contribution to China’s biomedical industry.
The seminar aims to strengthen international exchanges and cooperation in the fields of biotechnology and pharmaceuticals, and promote industrial development. During the event, experts and entrepreneurs from home and abroad gathered to share the latest research findings and discuss industry trends.
Participants expressed that with the rapid development of the global biotechnology and pharmaceutical industry, competition in this field is becoming increasingly fierce. Against this backdrop, as an important base for China’s biomedical industry, Shanghai is expected to play a greater role and contribute to the global biomedical industry.
It is reported that in order to continue promoting the development of the biomedical industry, the Shanghai Municipal Government will increase support in areas such as innovative drug research and development, result transformation, and talent training, accelerate the construction of a complete industrial chain system, and help “Shanghai Brand” innovative drugs enter the international market, enhancing China’s competitiveness in the global biomedical industry.
Looking forward, with the dual drive of policy support and market demand, Shanghai’s biomedical industry will continue to maintain rapid development, helping China’s status in the global biomedical field to rise continuously.
【来源】http://www.chinanews.com/cj/2024/05-21/10220875.shtml
Views: 1